These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27262870)

  • 1. Comparison of enteral ethanol and benzodiazepines for alcohol withdrawal in neurocritical care patients.
    Gipson G; Tran K; Hoang C; Treggiari M
    J Clin Neurosci; 2016 Sep; 31():88-91. PubMed ID: 27262870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Dose Gabapentin for the Treatment of Severe Alcohol Withdrawal Syndrome: A Retrospective Cohort Analysis.
    Levine AR; Carrasquillo L; Mueller J; Nounou MI; Naut ER; Ibrahim D
    Pharmacotherapy; 2019 Sep; 39(9):881-888. PubMed ID: 31278761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Use of Phenobarbital and Benzodiazepines in the Management of Alcohol Withdrawal Syndrome in Patients Requiring Neurological/Neurosurgical Critical Care: A Propensity-Matched Analysis.
    Norris M; Mak H; Fong CT; Walters AM; Hoang CV; Lele AV
    Cureus; 2024 Jun; 16(6):e61952. PubMed ID: 38978925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the appropriate use of a CIWA-Ar alcohol withdrawal protocol in the general hospital setting.
    Eloma AS; Tucciarone JM; Hayes EM; Bronson BD
    Am J Drug Alcohol Abuse; 2018; 44(4):418-425. PubMed ID: 28981333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of dexmedetomidine as an adjuvant to benzodiazepine-based therapy to decrease the severity of delirium in alcohol withdrawal in adult intensive care unit patients: a systematic review.
    Woods AD; Giometti R; Weeks SM
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):224-52. PubMed ID: 26447017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Symptom-Triggered Benzodiazepine Protocol Utilizing SAS and CIWA-Ar Scoring for the Treatment of Alcohol Withdrawal Syndrome in the Critically Ill.
    Sen S; Grgurich P; Tulolo A; Smith-Freedman A; Lei Y; Gray A; Dargin J
    Ann Pharmacother; 2017 Feb; 51(2):101-110. PubMed ID: 27733668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eliminating the benzos: A benzodiazepine-sparing approach to preventing and treating alcohol withdrawal syndrome.
    McCullough MA; Miller PR; Martin T; Rebo KA; Stettler GR; Martin RS; Cantley M; Shilling EH; Hoth JJ; Nunn AM
    J Trauma Acute Care Surg; 2024 Mar; 96(3):394-399. PubMed ID: 37934662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilizing CIWA-Ar to assess use of benzodiazepines in patients vulnerable to alcohol withdrawal syndrome.
    Nuss MA; Elnicki DM; Dunsworth TS; Makela EH
    W V Med J; 2004; 100(1):21-5. PubMed ID: 15119493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Adjunctive Dexmedetomidine in the Treatment of Alcohol Withdrawal Compared to Benzodiazepine Symptom-Triggered Therapy in Critically Ill Patients: The EvADE Study.
    Collier TE; Farrell LB; Killian AD; Kataria VK
    J Pharm Pract; 2022 Jun; 35(3):356-362. PubMed ID: 33297835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replacing the Clinical Institute Withdrawal Assessment-Alcohol revised with the modified Richmond Agitation and Sedation Scale for alcohol withdrawal to support management of alcohol withdrawal symptoms: potential impact on length of stay and complications.
    de Lemos J; Sharaf M; Moadebi S; Low-Beer S; Cassidy B; Sutherland JM; Deziel C; Nagendran S
    CJEM; 2024 Jun; 26(6):431-435. PubMed ID: 38796808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of benzodiazepine-resistant alcohol withdrawal across a healthcare system: Benzodiazepine dose-escalation with or without propofol.
    Wong A; Benedict NJ; Lohr BR; Pizon AF; Kane-Gill SL
    Drug Alcohol Depend; 2015 Sep; 154():296-9. PubMed ID: 26205315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine.
    Addolorato G; Balducci G; Capristo E; Attilia ML; Taggi F; Gasbarrini G; Ceccanti M
    Alcohol Clin Exp Res; 1999 Oct; 23(10):1596-604. PubMed ID: 10549990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Minnesota Detoxification Scale (MINDS) Assessment With High-Dose Front Loading Diazepam Treatment for Alcohol Withdrawal in Hospitalized Patients.
    Patel L; Beddow D; Kirven J; Smith CS; Hanovich S; Holaday K; Agboto V; St Hill CA
    Am J Med Sci; 2022 Jan; 363(1):42-47. PubMed ID: 34666063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Alcohol Withdrawal Syndrome: Phenobarbital vs CIWA-Ar Protocol.
    Tidwell WP; Thomas TL; Pouliot JD; Canonico AE; Webber AJ
    Am J Crit Care; 2018 Nov; 27(6):454-460. PubMed ID: 30385536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility and reliability of the SHOT: A short scale for measuring pretreatment severity of alcohol withdrawal in the emergency department.
    Gray S; Borgundvaag B; Sirvastava A; Randall I; Kahan M
    Acad Emerg Med; 2010 Oct; 17(10):1048-54. PubMed ID: 21040105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Gabapentin for Alcohol Withdrawal Syndrome in the Hospital Setting: A Randomized Open-Label Controlled Trial.
    DeFoster RE; Morgan RJ; Leung JG; Schenzel H; Vijapura P; Kashiwagi DT; Fischer KM; Philbrick KL; Kung S
    Subst Use Misuse; 2023; 58(13):1643-1650. PubMed ID: 37469099
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of the course and treatment of Alcohol Withdrawal Syndrome with the Clinical Institute Withdrawal Assessment for Alcohol - Revised: A systematic review-based meta-analysis.
    Pribék IK; Kovács I; Kádár BK; Kovács CS; Richman MJ; Janka Z; Andó B; Lázár BA
    Drug Alcohol Depend; 2021 Mar; 220():108536. PubMed ID: 33503582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes After Implementation of a Benzodiazepine-Sparing Alcohol Withdrawal Order Set in an Integrated Health Care System.
    Smith JT; Sage M; Szeto H; Myers LC; Lu Y; Martinez A; Kipnis P; Liu VX
    JAMA Netw Open; 2022 Feb; 5(2):e220158. PubMed ID: 35191968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and implementation of an alcohol withdrawal protocol using a 5-item scale, the Brief Alcohol Withdrawal Scale (BAWS).
    Rastegar DA; Applewhite D; Alvanzo AAH; Welsh C; Niessen T; Chen ES
    Subst Abus; 2017; 38(4):394-400. PubMed ID: 28699845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral ethanol prescribing for alcohol withdrawal syndrome: initial findings and future directions following implementation within a United Kingdom National Health Service setting.
    Quelch D; Copland A; Kaur J; Sarma N; Appleyard C; Nevill A; Davies N; Knight T; Williams G; Roderique-Davies G; John B; Bradberry S
    Clin Toxicol (Phila); 2024 Jul; 62(7):432-440. PubMed ID: 38913748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.